Phillip Mondy1, Tania Brama1, Jenny Fisher1, Carley N Gemelli2, Karen Chee1, Anastazia Keegan1, Daniel Waller3. 1. Clinical Services and Research, Australian Red Cross Blood Service, 17 O' Riordan Street, Alexandria, New South Wales, Australia. 2. Clinical Services and Research, Australian Red Cross Blood Service, 417 St Kilda Rd, Melbourne, Victoria, Australia. 3. Clinical Services and Research, Australian Red Cross Blood Service, 17 O' Riordan Street, Alexandria, New South Wales, Australia. Electronic address: dawaller@redcrossblood.org.au.
Abstract
BACKGROUND: This research examined the effect of autologous serum eye drops (ASED) on ocular symptoms, visual-related functioning and quality of life for patients failing other therapies. METHODS: Patients (N = 77) were asked to complete a survey prior to ASED use, and 2 and 12 months post-treatment. RESULTS: Significant improvements in symptom frequency and severity were documented for dryness, ocular pain and grittiness at 2 and 12 months. Patients felt more in control and required less help from others at 12 months. CONCLUSIONS: ASED produce sustained benefits to dry eye symptoms, improve feelings of control and reduce requirements for assistance from others.
BACKGROUND: This research examined the effect of autologous serum eye drops (ASED) on ocular symptoms, visual-related functioning and quality of life for patients failing other therapies. METHODS:Patients (N = 77) were asked to complete a survey prior to ASED use, and 2 and 12 months post-treatment. RESULTS: Significant improvements in symptom frequency and severity were documented for dryness, ocular pain and grittiness at 2 and 12 months. Patients felt more in control and required less help from others at 12 months. CONCLUSIONS: ASED produce sustained benefits to dry eye symptoms, improve feelings of control and reduce requirements for assistance from others.